Gan & Lee Pharmaceuticals. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 834.8 million compared to CNY 1,475.43 million a year ago.

Revenue was CNY 834.8 million compared to CNY 1,475.43 million a year ago. Net loss was CNY 197.61 million compared to net income of CNY 372.77 million a year ago. Basic loss per share from continuing operations was CNY 0.35 compared to basic earnings per share from continuing operations of CNY 0.66 a year ago.

Diluted loss per share from continuing operations was CNY 0.35 compared to diluted earnings per share from continuing operations of CNY 0.66 a year ago.